Neurosurgeons’ perspective on surgical treatment of glioblastoma: Practices, beliefs and willingness to randomize in surgical trials
Neuro-Oncology Advances · 12.01.2026 · 8 (1)
DOI: 10.1093/noajnl/vdag166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology Advances, online erschienen am 26.06.2026. Verfasst von Johnny Duerinck und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
The optimal extent of resection for glioblastoma remains debated, with high-level evidence from randomized controlled trials (RCTs) notably scarce. We aimed to evaluate international surgical practices, perceived quality of evidence, and feasibility of future RCTs through an international survey of neurosurgeons.
Methods
An international survey was distributed via European Organization for Research and Treatment of Cancer (EORTC), European Association of Neurosurgical Societies (EANS), Congress of Neurological Surgeons (CNS), and national societies. We used descriptive statistics to summarize surgical practices and univariate analysis and multivariate regression to identify demographic or institutional factors associated with clinical decision-making.
Results
Responses were received from 328 neurosurgeons across 38 countries. Participation was predominantly from Europe (81.1%), with 12.2% from North America. Most participants (82.9%) practiced in academic centers. While 60.4% identified supramarginal resection (SMR) as the optimal surgical goal, 37.8% aim for complete resection of enhancing tumor (CRET). Overall, 90.2% viewed the evidence for CRET as strong, compared to 63.1% for SMR. Despite these views, 72.6% expressed willingness to randomize patients between CRET and SMR, while 49.4% would be willing to randomize between partial resection and biopsy, if CRET is not feasible. Despite differences in individual practice, willingness to participate in RCTs remained consistent across geographic regions. The incomplete overlap between case-based decisions and general willingness to randomize highlights the importance of case-specific nuances. A paradox was observed where perceived weak evidence correlated with lower willingness to randomize(P < .001).
Conclusion
There is substantial global willingness among neurosurgeons to participate in surgical RCTs for glioblastoma. These findings provide a foundation for designing future international trials to resolve long-standing controversies regarding optimal surgical strategy for glioblastoma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
- Neuroprotection and Neuromodulation (NEUR) Research Group, Center for Neurosciences (C4N), Vrije Universiteit Brussel (VUB), Brussels, Belgium.
- Department of Neurosurgery, Universitaetsklinikum Erlangen-Nuremberg, Friedrich-Alexander-University Erlangen, Erlangen, Germany.
- Hospital Clínico San Carlos, Madrid, Spain.
- University of Liverpool, Liverpool, UK.
- Department of Neurosurgery, University Hospital Münster, Münster, Germany.
ORCID-Profile: Johnny Duerinck, Philipp Karschnia, Matthias Simon, Jorn Van Der Veken, Emilie Le Rhun, Michael Weller, Alireza Mansouri
Zitieren
APA
Duerinck, J., Lescrauwaet, L., Karschnia, P., Alfayate, R. P., Jenkinson, M. D., Molina, E. S., Simon, M., Gerritsen, J., Van Der Veken, J., Picart, T., Le Rhun, E., Minniti, G., Preusser, M., Weller, M., Wittens, M. M. J., Jakola, A. S., & Mansouri, A. (2026). Neurosurgeons’ perspective on surgical treatment of glioblastoma: Practices, beliefs and willingness to randomize in surgical trials. Neuro-Oncology Advances, 8(1). https://doi.org/10.1093/noajnl/vdag166
Vancouver
Duerinck J, Lescrauwaet L, Karschnia P, Alfayate RP, Jenkinson MD, Molina ES, et al. Neurosurgeons’ perspective on surgical treatment of glioblastoma: Practices, beliefs and willingness to randomize in surgical trials. Neuro-Oncology Advances. 2026;8(1). doi:10.1093/noajnl/vdag166
BibTeX
@article{Duerinck2026,
author = {Duerinck, Johnny and Lescrauwaet, Louise and Karschnia, Philipp and Alfayate, Rebeca Pérez and Jenkinson, Michael D and Molina, Eric Suero and Simon, Matthias and Gerritsen, Jasper and Van Der Veken, Jorn and Picart, Thiebaud and Le Rhun, Emilie and Minniti, Giuseppe and Preusser, Matthias and Weller, Michael and Wittens, Mandy Melissa Jane and Jakola, Asgeir S and Mansouri, Alireza},
title = {Neurosurgeons’ perspective on surgical treatment of glioblastoma: Practices, beliefs and willingness to randomize in surgical trials},
journal = {Neuro-Oncology Advances},
year = {2026},
volume = {8},
number = {1},
doi = {10.1093/noajnl/vdag166}
}
EUVIMED